Overview

Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy

Status:
Not yet recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This randomized controlled pilot clinical trial will enroll patients undergoing dynamic flexible bronchoscopy will be randomized to receive one of the two anesthetic combinations described above. The study will determine if there is a difference when considering patient and physician and satisfaction when performing DFB. Also, safety and efficacy of the two pharmacological combinations (fentanyl + midazolam and remifentanil + ketamine) used will be evaluated.
Phase:
Phase 4
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Treatments:
Fentanyl
Ketamine
Midazolam
Remifentanil